Study Finds Only 8% of Cardiac Device Alerts Urgent: Managing vast data from implantable cardiac devices requires a transformative technology and service platform
MALVERN, Pa. – June 4, 2019 – Geneva Health Solutions, a solutions provider of technology-enabled services in the implantable cardiac device space and a BioTelemetry, Inc. company, released cardiac device data findings at the 40th Annual (2019) Heart Rhythm Society (HRS) conference. Geneva’s proprietary cloud-based platform aggregates data from leading cardiac device manufacturer systems and provides care providers a single workflow portal to manage implantable device data, create and sign reports and integrate data with the electronic medical record. It is the only company that combines a proven enterprise platform and a quality service. The Geneva remote monitoring service helps cardiology providers manage the data deluge from cardiac devices, including implantable loop recorders (ILRs).
The moderated session titled, “The Role of Novel Remote Monitoring Data Management System Ameliorating Data Deluge from Implantable Loop Recorders,” was presented by Manish Wadhwa, M.D. F.H.R.S. (Fellow of the Heart Rhythm Society), Geneva’s Co-founder and Chief Medical Officer.
Dr. Wadhwa reviewed the following highlights at the conference:
- Over a three-month time period, over 22,000 ILR reports poured onto the Geneva platform from one cardiology practice.
- Approximately eight percent of these reports required immediate action, while seventy-eight percent of the reports did not contain useful information or represented data that could be stratified for timely but non-urgent review and reporting.
- The Geneva platform was designed to collate these reports and provide practitioners more meaningful reporting.
“The number of patients being implanted with diagnostic cardiac devices is increasing, coincident with the aging of our population,” said Dr. Wadhwa. “Our connected health solution reduces office staff burden and is another way to effectively manage rising healthcare costs. Geneva enhances the patient care experience and enables an efficient physician-patient partnership.”
“Through our platform and service, we have the unique ability to reduce the data management burden of already resource-stretched and time-constrained healthcare organizations, allowing more time for patient care,” said Yuri Sudhakar, BioTelemetry Senior Vice President and Geneva President. “Our technology-enabled services help drive in-office efficiencies and improve patient compliance while reducing the cost of care.”
Geneva was acquired by BioTelemetry in January 2019. BioTelemetry is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. Geneva transforms cardiac device data into actionable information to improve clinical workflow and patient care for electrophysiologist practices. Together, they create the most comprehensive connected health solution in the cardiology market.
About BioTelemetry and Geneva Healthcare
BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. We provide remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original equipment manufacturing that serves both healthcare and clinical research customers. More information can be found at www.gobio.com.
Founded by a team of cardiologists and technologists, Geneva Healthcare transforms cardiac device data into actionable information to improve clinical workflow and patient care for electrophysiologist practices across the country. It is the only solution offering to combine a patent-pending enterprise cloud-based platform and high-quality service for remote monitoring of implantable cardiac services. Learn more atwww.genvahealthsolutions.com.